Salter, K. H., Perez, B. A., Acharya, C. R., Walters, K. S., Anguiano, A., Anders, C. K., … Potti, A. (2008). Integration of clinico-pathologic variables, mRNA, and microRNA profiles represents an optimal strategy to predict sensitivity to chemotherapeutic agents in breast cancer. In Journal of Clinical Oncology (Vol. 26, pp. 14567–14567). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2008.26.15_suppl.14567

Salter, K. H., B. A. Perez, C. R. Acharya, K. S. Walters, A. Anguiano, C. K. Anders, H. K. Dressman, P. K. Marcom, J. R. Nevins, and A. Potti. “Integration of clinico-pathologic variables, mRNA, and microRNA profiles represents an optimal strategy to predict sensitivity to chemotherapeutic agents in breast cancer.” In Journal of Clinical Oncology, 26:14567–14567. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.14567.

Salter KH, Perez BA, Acharya CR, Walters KS, Anguiano A, Anders CK, et al. Integration of clinico-pathologic variables, mRNA, and microRNA profiles represents an optimal strategy to predict sensitivity to chemotherapeutic agents in breast cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 14567–14567.

Salter, K. H., et al. “Integration of clinico-pathologic variables, mRNA, and microRNA profiles represents an optimal strategy to predict sensitivity to chemotherapeutic agents in breast cancer.” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2008, pp. 14567–14567. Crossref, doi:10.1200/jco.2008.26.15_suppl.14567.

Salter KH, Perez BA, Acharya CR, Walters KS, Anguiano A, Anders CK, Dressman HK, Marcom PK, Nevins JR, Potti A. Integration of clinico-pathologic variables, mRNA, and microRNA profiles represents an optimal strategy to predict sensitivity to chemotherapeutic agents in breast cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 14567–14567.